Jump to main content
Jump to site search

Issue 101, 2015
Previous Article Next Article

4-Aminoquinoline-hybridization en route towards the development of rationally designed antimalarial agents

Author affiliations

Abstract

The resistance of Plasmodium falciparum, the causative agent of malaria, against quinine and chloroquine along with the lack of malaria vaccines has encouraged the development of various synthetic strategies towards biologically active scaffolds. An emerging strategy in medicinal chemistry, termed molecular hybridization, involves the covalent fusion of two or more drugs, active compounds, and/or pharmacophoric units into a hybrid compound, with fascinating activities and multiple but not essentially simultaneous pharmacological targets. 4-Aminoquinolines are considered as promising antimalarials and 4-aminoquinoline hybridization is considered as an attractive and feasible approach for the development of new molecular frameworks for averting and delaying the emergence of drug resistance along with improved efficacy. The present review article describes the recent developments on the 4-aminoquinoline-hybridization towards the development of new antimalarials.

Graphical abstract: 4-Aminoquinoline-hybridization en route towards the development of rationally designed antimalarial agents

Back to tab navigation

Publication details

The article was received on 13 Aug 2015, accepted on 09 Sep 2015 and first published on 11 Sep 2015


Article type: Review Article
DOI: 10.1039/C5RA16361G
Author version
available:
Download author version (PDF)
RSC Adv., 2015,5, 82676-82698

  •   Request permissions

    4-Aminoquinoline-hybridization en route towards the development of rationally designed antimalarial agents

    R. Raj, K. M. Land and V. Kumar, RSC Adv., 2015, 5, 82676
    DOI: 10.1039/C5RA16361G

Search articles by author

Spotlight

Advertisements